US 10172841
Inhibition of crystal growth of roflumilast
granted A61KA61K31/44A61K45/06
Quick answer
US patent 10172841 (Inhibition of crystal growth of roflumilast) held by Arcutis, Inc. expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arcutis, Inc.
- Grant date
- Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/44, A61K45/06, A61K47/10, A61K9/0014